RecallRadar

FDA Device recall Z-0640-2024

Incisive CT, model 728143 & 728144 running Software Version 5.0.0

On 2024-01-17 the FDA classified a Class II recall of Incisive CT, model 728143 & 728144 running Software Version 5.0.0 by Philips Healthcare Suzhou, citing multiple software issues which have the potential to lead to misdiagnosis due to image artifacts or incorrect image orientation labels, or the need for a CT rescan. These include:….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0640-2024
ClassificationClass II
Statusongoing
Initiated2022-12-23
Published2024-01-17
Last updated2026-09-13 11:57 UTC
CompanyPhilips Healthcare Suzhou
DistributionUS

Product

Incisive CT, model 728143 & 728144 running Software Version 5.0.0.

Reason

Multiple software issues which have the potential to lead to misdiagnosis due to image artifacts or incorrect image orientation labels, or the need for a CT rescan. These include: 1. Artifacts may occur on perfusion images, 2. Orientation label reversed in 2D images, 3. Auto voice does not work during the cardiac scan, 4. Auto voice and operators voice are too quiet, patient cant hear, 5. Not all of the images are reconstructed in some cases, 6. No image displayed on the console monitor after enabling CCT Single Scan, 7. Ring artifact appears in 32x0.625 collimation of bone scan when soft tissue view is selected, 8. A design defect where the error couch motion signal of couch firmware causes couch to identify current position as target position in next protocol, and 9. calcium scoring study split into separate series after loading to ISP.

Identifiers

code_infoUDI-DI: 00884838085015 (Model 728143) UDI-DI: 00884838105508 (Model 728144)

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:57 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0640-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.